These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 9890333)

  • 1. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane.
    Briggs A; Fenn P
    Health Econ; 1998 Dec; 7(8):723-40. PubMed ID: 9890333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trying to do better than average: a commentary on 'statistical inference for cost-effectiveness ratios'.
    Briggs A; Fenn P
    Health Econ; 1997; 6(5):491-5. PubMed ID: 9353649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Representing uncertainty: the role of cost-effectiveness acceptability curves.
    Fenwick E; Claxton K; Sculpher M
    Health Econ; 2001 Dec; 10(8):779-87. PubMed ID: 11747057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The handling of uncertainty in economic evaluations of health care strategies].
    Siani C; Moatti JP
    Rev Epidemiol Sante Publique; 2003 Apr; 51(2):255-76. PubMed ID: 12876511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affordability and cost-effectiveness: decision-making on the cost-effectiveness plane.
    Sendi PP; Briggs AH
    Health Econ; 2001 Oct; 10(7):675-80. PubMed ID: 11747050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care.
    O'Brien BJ; Drummond MF; Labelle RJ; Willan A
    Med Care; 1994 Feb; 32(2):150-63. PubMed ID: 8302107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bootstrap confidence intervals for cost-effectiveness ratios: some simulation results.
    Tambour M; Zethraeus N
    Health Econ; 1998 Mar; 7(2):143-7. PubMed ID: 9565170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A note on confidence intervals in cost-effectiveness analysis.
    Tambour M; Zethraeus N; Johannesson M
    Int J Technol Assess Health Care; 1998; 14(3):467-71. PubMed ID: 9780533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confidence intervals for cost/effectiveness ratios.
    Wakker P; Klaassen MP
    Health Econ; 1995; 4(5):373-81. PubMed ID: 8563835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies.
    Zethraeus N; Johannesson M; Jönsson B; Löthgren M; Tambour M
    Pharmacoeconomics; 2003; 21(1):39-48. PubMed ID: 12484802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods.
    O'Brien BJ; Briggs AH
    Stat Methods Med Res; 2002 Dec; 11(6):455-68. PubMed ID: 12516984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation.
    Briggs AH; Mooney CZ; Wonderling DE
    Stat Med; 1999 Dec; 18(23):3245-62. PubMed ID: 10602149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability.
    Barbieri M; Drummond M; Willke R; Chancellor J; Jolain B; Towse A
    Value Health; 2005; 8(1):10-23. PubMed ID: 15841890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resampling and multiplicity in cost-effectiveness inference.
    Obenchain RL
    J Biopharm Stat; 1999 Nov; 9(4):563-82. PubMed ID: 10576404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stochastic league tables: communicating cost-effectiveness results to decision-makers.
    Hutubessy RC; Baltussen RM; Evans DB; Barendregt JJ; Murray CJ
    Health Econ; 2001 Jul; 10(5):473-7. PubMed ID: 11466807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies.
    Briggs AH; O'Brien BJ; Blackhouse G
    Annu Rev Public Health; 2002; 23():377-401. PubMed ID: 11910068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertainty.
    Briggs A
    Value Health; 2005; 8(1):1-2. PubMed ID: 15841888
    [No Abstract]   [Full Text] [Related]  

  • 18. Who's better not best: appropriate probabilistic uncertainty analysis.
    Coyle D
    Int J Technol Assess Health Care; 2003; 19(3):540-5. PubMed ID: 12962341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyses of cost data in economic evaluations conducted alongside randomized controlled trials.
    Doshi JA; Glick HA; Polsky D
    Value Health; 2006; 9(5):334-40. PubMed ID: 16961551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data.
    Willan AR; O'Brien BJ
    Health Econ; 1999 May; 8(3):203-11. PubMed ID: 10348415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.